Skip to main content
Publicerad: 2020-05-27 14:55 | Uppdaterad: 2020-05-27 15:01

Aktuella utlysningar, vecka 22, 2020

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska utlysningar

Forskningsbidrag - Svenska Psoriasisförbundet

Stöder vetenskapliga projekt som syftar till att öka kunskapen om psoriasis och psoriasisartrit. 

Closing date: 15 June 2020

Further information 

 

Call for proposals for acceleration of vaccine development and global manufacturing capacity to prevent COVID-19 - Coalition for Epidemic Preparedness Innovations

Supports the rapid development of vaccines against COVID-19 with a goal of achieving licensure or emergency authorisation in 12 to 18 months or less and to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021. Applicants can apply for funding of their complete development plans, or parts of development plans. Applicants will be required to demonstrate both their ability to rapidly develop their vaccine candidate, as well as manufacture it at scale.

Closing date: 30 June 2020

Further information  

 

Natural sciences programme - Swedish Collegium for Advanced Study

Aims to advance cutting-edge research in the natural and medical sciences, as well as bridging the gap between these and the humanities and social sciences. The programme offers both symposia and residential fellowships.

Closing date: 1 July 2020

Further information 
 

Forskningsanslag inom medicin - Torsten Söderbergs Stiftelse

Stöder nya projekt nära klinisk användning. Bidrag uppgår till SEK 2 miljoner per projekt.

Closing date: 1 September 2020

Further information 

 

Call for Nominations – the 2021 Scheele Award

Nominate your candidate for the 2021 Scheele Award - marking the 50th time.
The Scheele Laureate will be appointed within the wide area of ongoing pharmaceutical research. The candidate should be an internationally recognized scientist, professionally active within the fields of drug research and drug development.

Deadline for nominations: 15 September, 2020. 

Further information (in pdf) and at Apotekarsocieteten

 

Utlysning av forskningsmedel för celiakiforskning 2020

Svenska Celiakiförbundets forskningsfond CELIAKIFONDEN delar årligen ut forskningsmedel för att öka kunskapen om sjukdomen celiaki.

Under 2019 delades totalt 400 000 kr ut till två olika forskningsprojekt. Forskare kan varje år ansöka om medel från fonden.

Ansökningsformuläret i PDF.

Deadline för ansökan: 10 augusti 2020.

Svenska Celiakiförbundet.

Europeiska utlysningar

ERC Advanced Grants 2020 - European Research Council, EU 

These support ground-breaking, high-risk projects carried out by an established, leading principal investigator in any field of research. Applicants are expected to be active researchers who have a track record of significant research achievements in the last 10 years, and should be exceptional leaders in terms of originality and significance of their research contributions.

Each grant is worth up to €2.5m, over five years. An additional €1m may be requested.

Closing date:  26 August 2020.

Please contact Grants Office if you are interested in applying.


Call for access -- European Network of Vaccine Research and Development, EU

This supports and accelerates vaccine-related projects in the preclinical phase of development, by providing access to the services and expertise contained within the Transvac infrastructure. COVID-19 vaccine development projects are encouraged to apply.

In addition to free access to services, Transvac may cover accommodation and travel costs if a physical visit to the infrastructure is needed.

Closing date: 5 August 2020

Further information 

 

Pezcoller Foundation/AACR international award for cancer research -- Pezcoller Foundation, IT 

The American Association for Cancer Research and the Pezcoller Foundation invite nominations for their international award for cancer research. This recognises a scientist who has made a major scientific discovery in basic cancer research or has made significant contributions to translational cancer research, and whose ongoing work holds promise for continued substantive contributions to progress in the field of cancer.

The award includes an unrestricted honorarium of €75,000 and full support for the recipient and a guest to attend the AACR annual meeting.

Closing date: 31 July 2020

Further information 

 

ECCO grants -- European Crohn's and Colitis Organisation, EUR

These support innovative scientific research in the area of inflammatory bowel diseases in Europe.

Young basic or clinical scientists up to the age of 40, or above if within five years of finishing gastrointestinal training or PhD graduation. They must be members of the society. Research is usually undertaken at the applicant’s home institution.

A total of eight awards, worth €80,000 each, are available for one year.

Closing date: 31 July 2020

Further information 

 

Networking project grants -- European Society for Paediatric Gastroenterology, Hepatology and Nutrition, EUR

These enable members to undertake research activities and network among centres at an international level. Activities may include interactive educational events and clinical networks. Proposals relevant to the society’s activities, such as the validation of guidelines, or clinical networks for testing treatment regimes or disease management, are encouraged.

Main applicants must be members of the society and all projects must include more than one country. Three grants, worth up to €50,000 each, are available.

Closing date: 31 July 2020 (Forecast: we have no information from the funder yet about the next call. Based on past experience, we forecast the deadline to be around July 2020. This call is repeated once a year.)

Further information 

 

Global exchange lecture courses grants -- European Molecular Biology Organisation, EUR

These support the organisation of lecture courses in life sciences. Scientists from anywhere in the world are eligible to apply. Courses must take place in EMBO associate member states or cooperating partner countries. Grants are worth up to €38,000.

Closing date: 1 August 2020

Further information 

Amerikanska utlysningar
 

Federal Funding agencies

Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional): NIH

This Funding Opportunity Announcement (FOA) invites grant applications that address priority gaps in understanding the role of nutrition in the care and development of preterm infants. Significant gaps exist in our understanding of: (1) nutrient needs of infants across this developmental period; (2) factors to be considered in the transitioning of infants from parenteral to enteral feeding; (3) specific needs of infants currently cared for in Neonatal Intensive Care Units (NICUs); and (4) other standards (e.g., growth standards, intrauterine accretion rates for essential and non-essential nutrients and other required bioactive substances, biomarkers for assessing nutritional status, etc.) to support the establishment of standards of nutritional care for preterm infants.

Deadline: November 30, 2020. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-HD-21-006
Further information

 

Epilepsy Research Program (ERP), Department of Defense (DoD), US

Idea Development Award - Letter of Intent due June 22, 2020

Level I:  Investigators at or above the level of postdoctoral fellow (e.g., research associates, fellows, medical residents, or equivalent) but below the level of Assistant Professor (or equivalent) at the time of the application deadline.
Mentor(s) required.
*       Maximum funding of $300,000 for direct costs (plus indirect costs)
*       Maximum period of performance is 3 years

Level II:  The Principal Investigator (PI) must be an independent investigator at or above the level of Assistant Professor (or equivalent)
*       Maximum funding of $500,000 for direct costs (plus indirect costs)
*       Maximum period of performance is 3 years
 

Quality of Life Award - Letter of Intent due June 22, 2020
Level I:  Investigators at or above the level of postdoctoral fellow (e.g., research associates, fellows, medical residents, or equivalent) but below the level of Assistant Professor (or equivalent) at the time of the application deadline.
Mentor required.
*       Maximum funding of $300,000 for direct costs (plus indirect costs)
*       Maximum period of performance is 3 years

Level II:  The PI must be an independent investigator at or above the level of Assistant Professor (or equivalent).
*       Maximum funding of $500,000 for direct costs (plus indirect costs)
*       Maximum period of performance is 3 years

Research Partnership Award - Letter of Intent due June 22, 2020
The initiating PI must be an independent investigator at or above the level of Assistant Professor (or equivalent).
Each named Co-PI must be at or above the level of assistant professor (or equivalent)

Level I is intended to support preclinical or pre-validation research.
*       Maximum funding of $1,300,000 in total costs
*       Maximum period of performance is 3 years

Level II is intended to support research requiring access to a patient cohort for a prospective study.

*       Maximum funding of $3,100,000 in total costs
*       Maximum period of performance is 4 years

Further information 

 

Peer Reviewed Alzheimer's Research Program (PRARP), Department of Defense (DoD), US

Convergence Science Research Award (CSRA) - Letter of Intent due June 22, 2020

Level I:  Investigators at the postdoctoral level (e.g., research associates, fellows, medical residents, or equivalent) but below the level of Assistant Professor (or equivalent) at the time of the application submission deadline.
*       Maximum funding of $225,000 for direct costs (plus indirect costs).
*       Maximum period of performance is 3 years.

Mentor Required.

Level II:  The Principal Investigator (PI) must be an independent investigator at or above the level of Assistant Professor (or equivalent).

*       Maximum funding of $500,000 for direct costs (plus indirect costs).
*       Maximum period of performance is 3 years.

Innovation in Care and Support Award (InCASA) - Letter of Intent due June 22, 200

Level I:  Investigators at the postdoctoral level (e.g., research associates, fellows, medical residents, or equivalent) but below the level of Assistant Professor (or equivalent) at the time of the application deadline.
*       Maximum funding of $225,000 for direct costs (plus indirect costs).
*       Maximum period of performance is 3 years.
Mentor Required.
 

Level II:  The PI must be an independent investigator at or above the level of Assistant Professor (or equivalent).
*       Maximum funding of $500,000 for direct costs (plus indirect costs).
*       Maximum period of performance is 3 years.
 

Research Partnership Award (RPA) - Letter of Intent due June 22, 2020
*         Funding limit is $1.3 million (M) in total costs.
*         Maximum period of performance is 3 years.
 

Accelerating Diagnostics for Traumatic Brain Injury Research Award (ADTBI) - Letter of Intent due June 22, 2020
*         Funding limit is $2.8M in total costs.
*         Maximum period of performance is 4 years.
 

Leveraging Approaches for Innovation in Care and Support Award (LEAP-InCASA) - Letter of Intent due June 22, 2020
Requires a Coordinating Center and at least two Partnering sites.
*         Funding limit is $2.8M in total costs.
*         Maximum period of performance is 4 years.

Further information 

 

Hearing Restoration Research Program (HRRP), Department of Defense (DoD), US

Focused Research Award – Preproposal due July 14, 2020

Independent investigators at all academic levels (or equivalent)

  • Preproposal is required; application submission is by invitation only.
  • Must address one or more of the FY20 HRRP Focus Areas.
  • Funding Level 1 supports exploratory, high-risk/high-reward research in the earliest stages of development.
  • Funding Level 2 supports the advancement of more mature research toward clinical translation.
  • Funding Level 2 may include a pilot clinical trial component where limited clinical testing of a novel intervention is conducted to inform the feasibility, rationale, and design of subsequent clinical trials.
  • Tinnitus or vestibular-related research is excluded.

Funding Level 1:

  • Maximum funding of $250,000 for direct costs (plus indirect costs)
  • The maximum period of performance is years.

Funding Level 2:

  • Maximum funding of $1,000,000 for direct costs (plus indirect costs)
  • The maximum period of performance is years.

Funding Level 2 with Pilot Clinical Trial Option:

  • Maximum funding of $1.250,000 for direct costs (plus indirect costs)
  • The maximum period of performance is years.

Further information 

 

Neurotoxin Exposure Treatment Parkinson’s Program (NETP), Department of Defense (DoD), US

Investigator-Initiated Research Award – Letter of Intent due August 18, 2020

Assistant Professor level or above (or equivalent)

Supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to neurotoxin exposure- and treatment-related Parkinson’s research. This award mechanism supports the full spectrum of research from basic science through clinical research.

  • Maximum funding of $1.2 million (M) for total costs (includes direct and indirect costs)
  • Maximum period of performance is 3 years
     

Early Investigator Research Award – Letter of Intent due August 18, 2020

Investigator must be a postdoctoral or clinical fellow, instructor, or assistant professor within 10 years of advanced degree or residency training (or equivalent)

Supports neurotoxin exposure- and treatment-related Parkinson’s research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor.

  • PIs must have a designated mentor who is an experienced Parkinson’s disease researcher.
  • Maximum funding of $400,000 I for total costs (includes direct and indirect costs)
  • Maximum period of performance 2 years
     

Synergistic Idea Award – Letter of Intent due August 18, 2020

Assistant Professor level or above (or equivalent).

  • Supports new ideas that represent synergistic approaches to neurotoxin exposure- and treatment-related Parkinson’s research involving two to four faculty-level (or equivalent) Principal Investigators (PIs).
  • Submission of a Letter of Intent is required prior to full application submissions.
  • Maximum funding of $3million (M) for total costs (includes direct and indirect costs)
  • Maximum period of performance is 4 years

Further information 

 

Prostate Cancer Research Program (PCRP), Department of Defense (DoD), US

All applications are required to address one or more of the following FY20 PCRP Overarching Challenges:

  • Improve the quality of life for survivors of prostate cancer
  • Develop treatments that improve outcomes for men with lethal prostate cancer
  • Reduce lethal prostate cancer in people of African descent, Veterans, and high-risk or underserved populations
  • Define the biology of lethal prostate cancer to reduce death
     

Prostate Cancer Pathology Resource Network Award - Letter of Intent due September 10, 2020
Independent investigators with a faculty-level appointment (or equivalent) with access to the appropriate facilities


*   Maximum funding of $6,000,000 for direct costs (plus indirect costs).
*   Maximum period of performance is 3 years.

Further information  

 

Foundation

Large research grants on education, Spencer Foundation, US

The Spencer Foundation invites intentions to apply for its large research grants on education. These support education research projects that will contribute to the improvement of education, broadly conceived. This program supports proposals with multiple disciplinary and methodological perspectives that develops new foundational knowledge that may also have a lasting impact on educational discourse.

The principal investigators and co-PIs must hold a doctorate in an academic discipline or professional field or have appropriate experience in an education research-related profession. Proposals are accepted from the US and internationally.

Grants are worth between USD 125,000 and USD 500,000 each for between one and five years.

Deadline: Intents to apply are due by 12 noon CT, 18 June 2020; full proposals due by 12 noon CT, 14 July 2020. This call is repeated 2 times a year.

Further information 

 

Newcomb Cleveland prize, American Association for the Advancement of Science (AAAS), US

The American Association for the Advancement of Science invites nominations for the Newcomb Cleveland prize. This recognizes an author or authors of a paper published in the research articles or reports sections of Science magazine. Each contest starts with the first issue of June and ends with the last issue of the following May.

Papers should include original research data, theory or synthesis, contribute to basic knowledge or introduce a technical achievement, and be the first publication of the author’s own work. Self-nominations are not accepted.

The award consists of a cash prize of USD 25,000, and complimentary registration, travel and accommodation expenses to attend the association’s annual meeting.

Deadline: June 30, 2020.

Further information

 

Operating grants, International Organisation for the Study of Inflammatory Bowel Disease, International

The International Organisation for the Study of Inflammatory Bowel Disease invites applications for its operating grants. These support members of the organisation in conducting research relevant to inflammatory bowel disease. The aim is to fund two clinical and two basic science projects.

Applicants must have an active or senior organisation member as a principal investigator or co-investigator.

Grants are worth up to USD 200,000 for a maximum period of one year. Preference will be given to small grants of up to USD 50,000.

Deadline: June 30, 2020.

Further information